Yair Lotan, MD

Yair Lotan, MD, is a co-leader of the post-market analysis and a professor of urology at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center.

Articles by Yair Lotan, MD

Future Directions for Cxbladder Triage and Microhematuria Evaluation

Yair Lotan, MDUrothelial Carcinoma Diagnostics | January 15, 2025

Dr. Lotan discusses risk stratification and outlines the next steps for integrating Cxbladder Triage into clinical practice.

STRATA Study: The Role of Cxbladder Triage in Reducing Cystoscopy Burden

Yair Lotan, MDUrothelial Carcinoma Diagnostics | January 8, 2025

Dr. Lotan describes the design and key findings of the STRATA trial using Cxbladder Triage for patients with microhematuria.

Developing, Validating AI Biomarkers to Predict Outcomes in BCG-Treated NMIBC

Yair Lotan, MDNon-Muscle Invasive Urothelial Carcinoma | May 7, 2024

Drs. Murray and Lotan review the development and validation of AI biomarkers to predict outcomes in BCG-treated NMIBC.

UGN-101 for UTUC: Longitudinal Follow-Up of Multicenter Study

Yair Lotan, MDUpper Tract Urothelial Carcinoma | May 7, 2024

Drs. Murray and Lotan highlight a recent multicenter study featuring longitudinal follow-up of UGN-101 for UTUC.

Novel Mitomycin-Based Therapy Shows Promise As “Game-Changing” Option for UTUC

Yair Lotan, MDUpper Tract Urothelial Carcinoma | February 10, 2023

Yair Lotan, MD, details the real-world use, effectiveness, and standard-of-care potential of UGN-101 for patients with UTUC.